EPOSBED-DEMO

Demonstration action for an Easy POSitioning for patients with reduced mobility

 Coordinatore INDUSTRIAS TOBIA S.A. 

 Organization address address: Calleja Vieja 62-64
postcode: 26080

contact info
Titolo: Mr.
Nome: Oscar
Cognome: Valdemoros Tobia
Email: send email
Telefono: +34 9 41211296
Fax: +34 9 41211444

 Nazionalità Coordinatore Spain [ES]
 Totale costo 569˙770 €
 EC contributo 313˙000 €
 Programma FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs
 Code Call FP7-SME-2011
 Funding Scheme CP
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-09-01   -   2013-11-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1 INDUSTRIAS TOBIA S.A. ES coordinator 141˙000.00
2    TECNOLOGIAS AVANZADAS INSPIRALIA SL

 Organization address address: CALLE MIGUEL VILLANUEVA 2 6 PISO PUERTA 3
city: LOGRONO
postcode: 26001

contact info
Titolo: Mr.
Nome: Alfredo
Cognome: Sanchez
Email: send email
Telefono: +34 9 1417 04 57
Fax: +34 9 1556 34 15

ES (LOGRONO) participant 69˙136.00
3    FOS FASEROPTISCHE SYSTEME MESSTECHNIK GMBH

 Organization address address: RUTGERSSTRASSE 40
city: SCHACHT AUDORF
postcode: 24790

contact info
Titolo: Dr.
Nome: Erhard
Cognome: Giese
Email: send email
Telefono: +49 4 3319065
Fax: +49 4 3319065

DE (SCHACHT AUDORF) participant 53˙100.00
4    LINCIS SOLUCOES INTEGRADAS PARA SISTEMAS DE INFORMACAO LDA

 Organization address address: Av Senhor Da Paciencia 36 B
city: BRAGA
postcode: 4705-448

contact info
Titolo: Mr.
Nome: Adelino
Cognome: Silva
Email: send email
Telefono: +35 1 2531048850
Fax: +35 1 253048851

PT (BRAGA) participant 49˙764.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

software    device    trials    market    frame    eposbed    adjust    patients    bed    ordm    beds    demonstration    lab    prototype       mobility    innovation    sensing    demo    hospital    clinical    train    hospitals    series    successful    medical    moving    successfully    limited   

 Obiettivo del progetto (Objective)

'The Eposbed Demo project aims to bring into the market a Specialty or Medical Bed for hospitals that assist patients with limited mobility in bed. Eposbed lab-scale prototype has been successfully developed in the FP7-SME-2007-1, Eposbed project nº 222064, although we only could perform those tasks devoted to its research development. In Eposbed Demo we aim to use the advanced knowledge, complementary skills, and technological developments acquired in former Eposbed project to successfully bring the product into a commercial stage by performing a series of Demonstration activities needed for its success in the market. After having dedicated time and resources for the successful development of Eposbed lab scale prototype, we must not underestimate the importance of the necessary activities to bring it to the next level: the market. It will require a series of trials, adjustments and market activities that need to be carefully planned and coordinated. Giving the characteristics of this product as medical equipment, Manufacturers must provide clinical data of product efficacy involving a series of clinical trials that are needed before it can be placed into the market. These trials also imply that we must train and educate clinical staff on the product use and advantages. This is only one part of the complex process of bringing our innovation to the market. To fully understand the requirements of Eposbed to build the gap between our successful innovation and the market, we have performed a SWOT analysis. This analysis study the strengths, weaknesses, opportunities and threats of EposbedTM considering the achievements and successful results of Eposbed project nº 222064 while identifying the needs for this demo project activities to bring it to the market'

Introduzione (Teaser)

About one third of nurses' injuries come from moving patients. An EU-funded project designed a bed that makes this task easier.

Descrizione progetto (Article)

Medical beds serve an important need for patients with limited mobility in both hospitals and homes. The project 'Demonstration action for an easy positioning for patients with reduced mobility' (http://www.eposbed.com (EPOSBED-DEMO)) has developed a medical bed for this population that makes use of technology.

The primary project objectives were to find a sensing device for a bed that is more affordable than the one currently in place, adjust the software to make it more efficient, adjust the motor of the bed, develop a lighter bed frame, and conduct clinical trials.

During the first part of the project, a lab-scale prototype was developed. Researchers then started work to prove this product is viable in the market. To accomplish this goal, they aimed to produce an industrial-scale prototype and train medical professionals.

The project accomplished many of its goals. A German manufacturer was selected to redesign aspects of the bed. A new bed frame was developed, along with a redesigned sensing device and updated software. The ethical committee cleared the project, and the bed is now ready for clinical trials at the Hospital San Pedro in Spain.

Press documents have been disseminated to spread awareness about the bed, and developers have applied for patents in the EU and the United States to extend the reach of this development.

This bed will allow users to have more mobility and autonomy over their movements. It will also take some of the physical burden of moving patients off hospital workers and caregivers. Importantly, however, this bed has the potential to improve the quality of life for patients largely confined to their beds.

Altri progetti dello stesso programma (FP7-SME)

EFFIDRIP (2012)

"Enabling next generation commercial service-oriented, automatic irrigation management systems for high efficient use of water, fertilizers and energy in drip irrigated tree crops."

Read More  

ECOPIX (2014)

"Eco-friendly digital advertising display, based on novel printable electrochromic polymers"

Read More  

THRIVE-RITE (2012)

"Natural Compounds to enhance Productivity, Quality and Health in Intensive Farming Systems."

Read More